Results 121 to 130 of about 48,654 (175)

rTMS over bilateral superior temporal gyri combined with auditory-speech training for post-stroke pure word deafness: a case report. [PDF]

Front Psychol
Chen X, Chang Y, Leng Y, Chen X, Li Y.
europepmc   +1 more source

Untargeted Metabolomics Analysis Reveals Potential Metabolic Targets in Gemcitabine-Treated Pancreatic Cancer Cells. [PDF]

Metabolites
Tiwari AP, Rushing BR, Silva L, Sumner SJ, Mukherjee P.   +4 more
europepmc   +1 more source

MicroRNA profiling in serum and correlation with tumor tissue and clinicopathological parameters in periampullary carcinoma. [PDF]

Ann Hepatobiliary Pancreat Surg
Varshney VK, Sharma S, Anjali S, Shaikh MA, Selvakumar B, Varshney P, Agarwal L, Soni S, Dixit SG, Saluja SS.   +9 more
europepmc   +1 more source

Specific targeting of cancer cell mitochondria with a malaria drug improves pancreatic cancer outcome. [PDF]

Sci Rep
Ou Y, Lim A, Wang R, Mir N, Calsavara VF, Wang Q, Zhang Y, Pandol SJ, Edderkaoui M.   +8 more
europepmc   +1 more source

GMPS drives pancreatic cancer progression via suppressing DNA damage, STING activation and cellular senescence. [PDF]

Transl Oncol
Li Y, Zhang Z, Li D, Zhou C, Chen Y, Zhu C, Yang J, Tang R, Wang W, Yu X, Xu J.   +10 more
europepmc   +1 more source

LncRNA YIYA drives pancreatic cancer proliferation under high-glucose conditions by reinforcing a RAS-PKM2-dependent Warburg phenotype. [PDF]

FEBS Lett
Garge ND, Sharma A, Mukherjee S, Chowdhury R.   +3 more
europepmc   +1 more source

Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma. [PDF]

Cancer Res
Woo SM, Kang JH, Choi W, Lee H, Jang H, Sim SH, Chun JW, Koh EB, Kim C, Ham W, Hong W, Kang M, Park J, Han S, Kim JW, Lee EW, Lee WJ, Kim SY.   +17 more
europepmc   +1 more source

TGFβ Blockade by Inhibition of Enolase-1-Mediated Plasmin Targets Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma. [PDF]

Oncol Res
Chen ML, Chung IC, Huang KC, Chao KSC, Yuan TT.   +4 more
europepmc   +1 more source

Chemotherapy-induced senescence promotes stroma stiffness and antioxidant adaptation to promote chemoresistance in pancreatic ductal adenocarcinoma. [PDF]

Nat Commun
Liu X, Huang Z, Yang B, Du Y, Sun Y, Zhang E, Kang X, Xue C, Chen K, Ma Y, Tian X, Xu X, Yang Y.   +12 more
europepmc   +1 more source

The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation. [PDF]

Oncotarget
Ofosu-Asante K, Lazarte JMS, Burra AG, Lamango NS.   +3 more
europepmc   +1 more source